scorecardresearch
Add as a preferred source on Google
Friday, November 21, 2025
TopicDiabetes Drug

Topic: Diabetes Drug

India sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arena

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, as per estimates.

In Brazil’s São Paulo, armed gangs on the hunt for something more sought-after than gold—Ozempic

Desperation for ‘weight-loss’ drug that’s used to treat type-2 diabetes is real. Break-ins at pharmacies have also been reported in Michigan, US, and Santiago de Copostela, Spain. 

I was a pregnant penguin, see my before-after pics. 66-yr-old’s Ozempic to Mounjaro journey

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and the obese, but everyone wants in—even those who don’t need them.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

On Camera

India can face multi-front conflicts with hostile Dhaka. New Delhi missed chance to engage BNP

India's projects related to BIMSTEC, Look-East-Act-East and Indian Ocean Rim Association could suffer a setback, impacting trade with South Asia and the South-South Cooperation agenda.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Tejas fighter aircraft crashes at Dubai Air Show

The aircraft was undertaking a manoeuvre when it plummeted to the ground and burst into a ball of flame. Visuals suggest that the pilot was unable to eject.

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.